Component

Human modafinil pregnancy-risk observations and precautions

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Regulatory pregnancy concerns and contraceptive precautions are based on safety assessments, not proof of a specific arousal-circuit teratogenic mechanism.

    Experimental context and source evidence
    evidence_access
    Official pregnancy and method-specific contraception guidance read; page dated 2020-11-16. Official safety guidance read; March 2011 article with subsequent pregnancy update. Not a primary intervention study.
    experimental_model
    Official regulatory safety guidance; precaution distinguished from measured mechanism.
    interpretation_status
    Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
    limitations
    Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.
    plain_language
    Regulatory pregnancy concerns and contraceptive precautions are based on safety assessments, not proof of a specific arousal-circuit teratogenic mechanism.
    primary_references
    MHRA modafinil pregnancy and contraception update | https://www.gov.uk/drug-safety-update/modafinil-provigil-increased-risk-of-congenital-malformations-if-used-during-pregnancy
    primary_references
    MHRA restricted indication and safety advice | https://www.gov.uk/drug-safety-update/modafinil-provigil-now-restricted-to-narcolepsy
    source_locator
    Reviewed reference lines 168-168; exact primary location described in quoted passage where extracted.

    Modafinil: detailed mechanisms of action (reviewed 3 October 2026) · lines 168–168

    Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Official regulatory safety guidance; precaution distinguished from measured mechanism. · Recorded from source · Recorded from source

    Psychiatric, cardiovascular and pregnancy concerns need their own safety records. A proposed circuit mechanism cannot rule them out. Pregnancy risk assessments should distinguish observed associations, uncertainty and precautionary recommendations. [Regulatory safety assessment](https://www.gov.uk/drug-safety-update/modafinil-provigil-now-restricted-to-narcolepsy), [pregnancy advice](https://www.gov.uk/drug-safety-update/modafinil-provigil-increased-risk-of-congenital-malformations-if-used-during-pregnancy)
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.